Clinical trials
Terminated HIV Infections trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 3 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2022 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 7 |
| ANRS, Emerging Infectious Diseases | 1 |
| Agouron Pharmaceuticals | 1 |
| Centers for Disease Control and Prevention | 1 |
| French National Agency for Research on AIDS and Viral Hepatitis | 1 |
| Harvard School of Public Health (HSPH) | 1 |
| ICN Pharmaceuticals | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| McGill University | 1 |
| National Institute of Mental Health (NIMH) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 26 |
| Acquired Immunodeficiency Syndrome | 5 |
| AIDS-Related Opportunistic Infections | 2 |
| Immunologic Deficiency Syndromes | 2 |
| Lymphoma | 2 |
| AIDS Dementia Complex | 1 |
| AIDS-Related Complex | 1 |
| Bone Diseases, Metabolic | 1 |
| Brain Neoplasms | 1 |
| COVID-19 | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.